20 results
424B5
GNLX
Genelux Corp
24 May 24
Prospectus supplement for primary offering
5:19pm
candidates that successfully complete clinical trials;
maintain, expand and protect our intellectual property portfolio;
hire additional research
424B5
GNLX
Genelux Corp
23 May 24
Prospectus supplement for primary offering
4:59pm
and protect our intellectual property portfolio;
hire additional research and development, clinical, scientific and management personnel;
add operational
10-Q
rzb pnsxdfi8ob86
15 May 23
Quarterly report
12:00am
10-K
5spo3
29 Mar 23
Annual report
5:12pm
S-1/A
4dywlvq4
29 Aug 22
IPO registration (amended)
4:01pm
S-1
grtzkulz76w7ka1a
24 Jun 22
IPO registration
4:35pm
DRS/A
5mt 9ptjxoiv42tel7h
20 May 22
Draft registration statement (amended)
12:00am
DRS/A
EX-10.10
t1mkh c5p
24 Jun 21
Draft registration statement (amended)
12:00am
DRS/A
qh8h32yrr6b0
24 Jun 21
Draft registration statement (amended)
12:00am
DRS
nrcg 1ilpzj
7 May 21
Draft registration statement
12:00am
DRS
EX-10.10
xo0ofxsh7m4aw6w
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next